StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) income statement

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.09−0.23 (-17.42%)

Close on Nov 20, 2026Market cap $18.17MP/E –Yield –

See a number that looks wrong?